Melatonin Loaded in Injectable Platelet-Rich Fibrin in the Management Periodontitis

NCT07316582 · Status: ENROLLING_BY_INVITATION · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 60

Last updated 2026-01-05

No results posted yet for this study

Summary

melatonin loaded in injectible platelet rich fibrin in treatment of periodontitis

Conditions

  • Periodontitis Stage II

Interventions

DRUG

Melatonin-Loaded Injectable Platelet-Rich Fibrin

patients will be included in this group receiving SRP with Melatonin loaded in (I-PRF) using insulin syringe for injection

BIOLOGICAL

injectible platelet rich fibrin (i-PRF )

patients will be included in this group receiving (SRP) with local application of i-PRF

Sponsors & Collaborators

  • Al-Azhar University

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
20 Years
Max Age
60 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2025-11-01
Primary Completion
2026-06-01
Completion
2026-07-01

Countries

  • Egypt

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07316582 on ClinicalTrials.gov